optimization of drug combinations
drug repositioning
pipeline of drug combinations
optimization of existing drug combinations
drug combination strategies
identification of new drug combinations
knowledge of individual drug stimuli
addition of innovative drugs
multiple drugs
know-how of DrugSynergy
business development strategies
data-driven systems biology approach
innovative systems biology large-scale data-driven approach
innovative pipelines
Current strategies
limited efficacy
public data
licensing new IP
chronic inflammatory diseases
treatment efficacy
excessive toxicity
complex physiopathology of human chronic diseases
lower undesired toxicity
major biomedical challenge
possible non-exclusive scenarios
industrial partnership department
highest possible resolution
limited number of cellular outputs
networks robustness
feedback loops
service
growing need
health challenges
screening of small molecule libraries
socio-economic impact
cancer
cross-talks
academic structure
start-up company
intellectual property
biotech companies
order
resistance
man limitations
databases
response
computational analysis workflow
Institute
interactions
past years
goals
options